EBS

Emergent Biosolutions Inc

• Seeking Alpha·1d ago

  Emergent BioSolutions: Down 40%+ From Recent Highs And Likely More To Come

• Seeking Alpha·06/01 14:20

  These 10 small-cap U.S. healthcare giants rank among the market's most attractively valued stocks

• TipRanks·06/01 10:30

  Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Emergent Biosolutions (EBS) and Compass Therapeutics (CMPX)

• Dow Jones·05/28 21:02

  Emergent BioSolutions Gets $64.5M Contract Modification From HHS for Botulism Treatment

• TipRanks·05/28 21:00

  Emergent BioSolutions awarded $64.5M HHS contract modification

• Benzinga·05/28 20:22

  Emergent BioSolutions Wins $64.5M U.S. HHS Contract Modification To Supply Botulism Antitoxin BAT Under Existing 10-Year Agreement

• Benzinga·05/18 15:25

  U.S. CDC Says Will Enhance Screening And Monitoring Of Travelers Arriving From Areas Affected By Ebola Outbreaks; Will Coordinate With Airlines, Others To Manage Travelers Who May Have Already Been Exposed To Ebola; Will Enhance Contract Tracing, Hospital Readiness Nationwide

• TipRanks·05/18 13:18

  Emergent BioSolutions receives Saudi approval for ACAM2000 vaccine

• Benzinga·05/18 13:02

  Emergent BioSolutions Announces Saudi Approval For ACAM2000, Its Smallpox and Mpox Vaccine

• TipRanks·05/04 10:30

  Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Artiva Biotherapeutics, Inc. (ARTV) and Emergent Biosolutions (EBS)

• Simply Wall St·05/02 07:45

  Emergent BioSolutions (EBS) Q1 EPS Profit Challenges Narrative Of Persistent Losses

• TipRanks·05/02 00:45

  Emergent BioSolutions Earnings Call Highlights Turnaround Momentum

• Seeking Alpha·05/01 15:12

  Emergent outlines $170M-$185M Q2 revenue outlook while maintaining $720M-$760M 2026 revenue guidance

• TipRanks·04/30 22:21

  Emergent BioSolutions Posts Weak Q1 Results Amid Turnaround

• Benzinga·04/30 21:54

  Emergent BioSolutions Q1 2026 Earnings Call: Complete Transcript